Fine Organic Industries (FINEORG) Q4 24/25 earnings summary

Executive summary

• Consolidated revenue grew 19% year-over-year to ₹3,023 crore in FY25, with exports at 57% and domestic sales at 43%.

• All plants operated near full capacity except Patalganga, which is ramping up; full operations resumed at Badlapur after a temporary shutdown.

• Strategic expansions include new SEZ facility in Maharashtra, planned U.S. manufacturing unit, and subsidiaries in the USA and UAE.

• Audited standalone and consolidated results for FY25 were approved with unmodified auditor opinions; new auditors appointed for five years.

• Final dividend of ₹11 per share recommended for FY25.

Financial highlights

• FY25 consolidated EBITDA was ₹534 crore (margin 17.7%), and PAT was ₹410 crore (margin 13.6%).

• Standalone FY25 revenue was ₹2,205 crore, EBITDA ₹481 crore (margin 21.8%), and PAT ₹390 crore (margin 17.7%).

• Q4FY25 consolidated revenue rose 11% year-over-year to ₹607 crore; PAT declined 15% to ₹97 crore.

• EPS for FY25 was ₹133.89 (consolidated) and ₹127.09 (standalone).

• Inventory days increased by 13 due to higher raw material and finished goods holdings.

Outlook and guidance

• Raw material and freight costs increased in FY25 but are expected to stabilize; management expects growth to accelerate post-SEZ and U.S. plant commissioning.

• Plans to expand international presence with new subsidiaries in the USA and UAE.

• Volume growth for the next two years projected at 5-6% CAGR, limited by current capacity.